These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 213721)

  • 21. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes.
    Katz P; Simone CB; Henkart PA; Fauci AS
    J Clin Invest; 1980 Jan; 65(1):55-63. PubMed ID: 6243141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of superoxide anion generation in antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity.
    Capsoni F; Meroni PL; Lazzarin A; Marzatico O
    Boll Ist Sieroter Milan; 1979 Sep; 58(4):300-5. PubMed ID: 233340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different activation pathways involved in antibody-dependent and immune-complexes-triggered cytotoxicity mediated by neutrophils.
    Geffner JR; Giordano M; Serebrinsky G; Isturiz MA
    Clin Exp Immunol; 1988 Dec; 74(3):471-6. PubMed ID: 2853017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-dependent cellular cytotoxicity and chemiluminescence as a tool for studying the mechanism of anti-glomerular basement membrane nephritis. The role of the cytotoxic potential of polymorphonuclear granulocytes and monocytes.
    Mossmann H; Hoyer B; Walz W; Himmelspach K; Hammer DK
    Immunology; 1984 Nov; 53(3):545-52. PubMed ID: 6490096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micro-scission of YAC tumor cells during antibody-dependent cellular cytotoxicity mediated by human neutrophils.
    Zhou M; Petty HR
    Eur J Cell Biol; 1989 Oct; 50(1):201-8. PubMed ID: 2482179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the role of superoxide radicals in neutrophil-mediated cytotoxicity.
    Simchowitz L; Spilberg I
    Immunology; 1979 Jun; 37(2):301-9. PubMed ID: 223976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the human peripheral effector cells mediating antibody dependent cellular cytotoxicity against allogenic cells.
    Donner M; Raffoux C; Streiff F
    Clin Exp Immunol; 1979 Dec; 38(3):549-60. PubMed ID: 535187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil--mediated cytotoxicity against tumour cells: state of art.
    Dallegri F; Ottonello L
    Arch Immunol Ther Exp (Warsz); 1992; 40(1):39-42. PubMed ID: 1362490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma theileri: antibody-dependent killing by purified populations of bovine leucocytes.
    Townsend J; Duffus WP
    Clin Exp Immunol; 1982 May; 48(2):289-99. PubMed ID: 7105486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-dependent cell-mediated cytotoxicity in pigs.
    Zarkower A; Eskew ML; Scheuchenzuber WJ; Ferguson FG; Confer F
    Am J Vet Res; 1982 Sep; 43(9):1590-3. PubMed ID: 7149406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of recovery from viral infections: destruction of infected cells by neutrophils and complement.
    Grewal AS; Rouse BT; Babiuk LA
    J Immunol; 1980 Jan; 124(1):312-9. PubMed ID: 6243147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse immunoglobulin isotypes mediating cytotoxicity of target cells by eosinophils and neutrophils.
    López AF; Strath M; Sanderson CJ
    Immunology; 1983 Mar; 48(3):503-9. PubMed ID: 6219064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodies.
    Heijnen IA; Rijks LJ; Schiel A; Stockmeyer B; van Ojik HH; Dechant M; Valerius T; Keler T; Tutt AL; Glennie MJ; van Royen EA; Capel PJ; van de Winkel JG
    J Immunol; 1997 Dec; 159(11):5629-39. PubMed ID: 9548506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mechanism for neutrophil-mediated lysis of human neuroblastoma cells.
    Barker E; Reisfeld RA
    Cancer Res; 1993 Jan; 53(2):362-7. PubMed ID: 8417829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil-mediated antibody-dependent cellular cytotoxicity: morphological concomitants of 51Cr-release.
    Dale MM; Muid RE; Wilson HK
    Immunology; 1983 Jun; 49(2):401-3. PubMed ID: 6852874
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic granulomatous disease.
    Bassani F; Capsoni F; Lazzarin A; Rossi A
    Pediatr Radiol; 1981; 11(2):105-8. PubMed ID: 7301444
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation of monocyte and granulocyte antibody-dependent cytotoxicity by phorbol myristate acetate.
    Klassen DK; Conkling PR; Sagone AL
    Infect Immun; 1982 Mar; 35(3):818-25. PubMed ID: 7068217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts.
    Ihara T; Starr SE; Ito M; Douglas SD; Arbeter AM
    J Virol; 1984 Jul; 51(1):110-6. PubMed ID: 6328030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic mechanism in white blood cells.
    Capsoni F; Meroni PL; Ciboddo GF; Colombo G
    N Engl J Med; 1979 Jan; 300(1):44. PubMed ID: 213721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.